Zhongjin Qichen
3
22M
2
1
0.33
- Areas of investment
Summary
The leading representative office of defined Corporate Investor is situated in the Suzhou. The company was established in Asia in China.
For fund there is a match between the location of its establishment and the land of its numerous investments - China. Among the various public portfolio startups of the fund, we may underline Bellen, Smartee Denti-Technology Besides, a startup requires to be at the age of 11-15 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Chemical, Health Care. The fund has specific favorite in a number of founders of portfolio startups.
The fund is generally included in less than 2 deals every year. The real fund results show that this Corporate Investor is 13 percentage points more often commits exit comparing to other companies. Deals in the range of 10 - 50 millions dollars are the general things for fund. The important activity for fund was in 2017.
The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Zhongjin Qichen, startups are often financed by THG Ventures, Legend Capital, Gefeiyueren. The meaningful sponsors for the fund in investment in the same round are QianHai Equity Investment, Neovision Capital, Legend Capital. In the next rounds fund is usually obtained by QianHai Equity Investment, Junlian Yikang, Apricot Capital.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 1
- Follow on index
- 0.33
- Investments by industry
- Product Research (2)
- Biotechnology (2)
- Medical (2)
- Chemical (2)
- Pharmaceutical (2) Show 5 more
- Investments by region
-
- China (3)
- Peak activity year
- 2019
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 16
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Bellen | 27 Sep 2018 | Biotechnology, Medical, Pharmaceutical, Chemical, Product Research | Late Stage Venture | 30M | China, Beijing, Dongcheng District |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.